Literature DB >> 24325774

Kratom exposures reported to Texas poison centers.

Mathias B Forrester1.   

Abstract

Kratom use is a growing problem in the United States. Kratom exposures reported to Texas poison centers between January 1998 and September 2013 were identified. No kratom exposures were reported from 1998 to 2008 and 14 exposures were reported from 2009 to September 2013. Eleven patients were male, and 11 patients were in their 20s. The kratom was ingested in 12 patients, inhaled in 1, and both ingested and inhaled in 1. Twelve patients were managed at a healthcare facility and the remaining 2 were managed at home.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24325774     DOI: 10.1080/10550887.2013.854153

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  11 in total

1.  The Chemistry of Kratom [Mitragyna speciosa]: Updated Characterization Data and Methods to Elucidate Indole and Oxindole Alkaloids.

Authors:  Laura Flores-Bocanegra; Huzefa A Raja; Tyler N Graf; Mario Augustinović; E Diane Wallace; Shabnam Hematian; Joshua J Kellogg; Daniel A Todd; Nadja B Cech; Nicholas H Oberlies
Journal:  J Nat Prod       Date:  2020-06-29       Impact factor: 4.050

Review 2.  The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.

Authors:  Marcus L Warner; Nellie C Kaufman; Oliver Grundmann
Journal:  Int J Legal Med       Date:  2015-10-28       Impact factor: 2.686

Review 3.  Substance-induced Psychosis in Youth.

Authors:  David Beckmann; Kelsey Leigh Lowman; Jessica Nargiso; James McKowen; Lisa Watt; Amy M Yule
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2019-09-23

4.  Pharmacokinetics of mitragynine in man.

Authors:  Satariya Trakulsrichai; Korbtham Sathirakul; Saranya Auparakkitanon; Jatupon Krongvorakul; Jetjamnong Sueajai; Nantida Noumjad; Chonlaphat Sukasem; Winai Wananukul
Journal:  Drug Des Devel Ther       Date:  2015-04-29       Impact factor: 4.162

5.  Kratom, an Emerging Drug of Abuse, Raises Prolactin and Causes Secondary Hypogonadism: Case Report.

Authors:  Lauren LaBryer; Rohan Sharma; Kaustubh Suresh Chaudhari; Mitali Talsania; Robert Hal Scofield
Journal:  J Investig Med High Impact Case Rep       Date:  2018-03-16

6.  Histologic Characterization of Kratom Use-Associated Liver Injury.

Authors:  Michael Riverso; Michael Chang; Consuelo Soldevila-Pico; Jinping Lai; Xiuli Liu
Journal:  Gastroenterology Res       Date:  2018-02-23

Review 7.  Kratom-Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review.

Authors:  Steven C Eastlack; Elyse M Cornett; Alan D Kaye
Journal:  Pain Ther       Date:  2020-01-28

8.  Kratom policy: The challenge of balancing therapeutic potential with public safety.

Authors:  Walter C Prozialeck; Bonnie A Avery; Edward W Boyer; Oliver Grundmann; Jack E Henningfield; Andrew C Kruegel; Lance R McMahon; Christopher R McCurdy; Marc T Swogger; Charles A Veltri; Darshan Singh
Journal:  Int J Drug Policy       Date:  2019-05-16

Review 9.  Mitragyna Species as Pharmacological Agents: From Abuse to Promising Pharmaceutical Products.

Authors:  Islamudin Ahmad; Wisnu Cahyo Prabowo; Muhammad Arifuddin; Jaka Fadraersada; Niken Indriyanti; Herman Herman; Reza Yuridian Purwoko; Firzan Nainu; Anton Rahmadi; Swandari Paramita; Hadi Kuncoro; Nur Mita; Angga Cipta Narsa; Fajar Prasetya; Arsyik Ibrahim; Laode Rijai; Gemini Alam; Abdul Mun'im; Sukanya Dej-Adisai
Journal:  Life (Basel)       Date:  2022-01-27

Review 10.  Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries.

Authors:  Eduardo Cinosi; Giovanni Martinotti; Pierluigi Simonato; Darshan Singh; Zsolt Demetrovics; Andres Roman-Urrestarazu; Francesco Saverio Bersani; Balasingam Vicknasingam; Giulia Piazzon; Jih-Heng Li; Wen-Jing Yu; Máté Kapitány-Fövény; Judit Farkas; Massimo Di Giannantonio; Ornella Corazza
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.